Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312143485> ?p ?o ?g. }
- W4312143485 endingPage "100913" @default.
- W4312143485 startingPage "100913" @default.
- W4312143485 abstract "Chemoresistance remains a major challenge in gastric cancer (GC). Chromodomain helicase DNA-binding protein 4 (CHD4) mediated chromatin remodeling plays critical roles in various tumor types, but its role in chemoresistance in GC remains uncharacterized. CHD4 expression was examined by immunohistochemistry and Western blotting. The role of CHD4 on cell proliferation and chemoresistance of GC was examined in vitro and in vivo. Immunoprecipitation and liquid chromatography-mass spectrometry were used to identify CHD4-binding proteins and a proximity ligation assay was used to explore protein-protein interaction. Chemoresistance is associated with upregulation of CHD4 in the tumor tissues of GC patients. Overexpression of CHD4 increased chemoresistance and cell proliferation. Knockdown of CHD4 induced cell apoptosis and cell cycle arrest. CHD4 mediates the decrease of the intracellular concentration of cisplatin by inducing drug efflux. Additionally, CHD4 promotes the interaction between ERK1/2 and MEK1/2, resulting in continuous activation of MEK/ERK pathway. Knockdown of CHD4 in GC increased sensitivity to chemotherapy and suppressed tumor growth in a mouse xenograft model. This study identifies CHD4 dominated multi-drug efflux as a promising therapeutic target for overcoming acquired chemoresistance in GC." @default.
- W4312143485 created "2023-01-04" @default.
- W4312143485 creator A5002487860 @default.
- W4312143485 creator A5005153006 @default.
- W4312143485 creator A5015850101 @default.
- W4312143485 creator A5029636776 @default.
- W4312143485 creator A5049061801 @default.
- W4312143485 creator A5051324146 @default.
- W4312143485 creator A5057222500 @default.
- W4312143485 creator A5058970294 @default.
- W4312143485 creator A5061154616 @default.
- W4312143485 creator A5071336437 @default.
- W4312143485 creator A5076005692 @default.
- W4312143485 creator A5077972623 @default.
- W4312143485 date "2023-01-01" @default.
- W4312143485 modified "2023-10-16" @default.
- W4312143485 title "CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis" @default.
- W4312143485 cites W1525573602 @default.
- W4312143485 cites W1706395004 @default.
- W4312143485 cites W1901052188 @default.
- W4312143485 cites W1969576898 @default.
- W4312143485 cites W1978780879 @default.
- W4312143485 cites W1981177510 @default.
- W4312143485 cites W2003678246 @default.
- W4312143485 cites W2014646239 @default.
- W4312143485 cites W2015055491 @default.
- W4312143485 cites W2020084014 @default.
- W4312143485 cites W2053118297 @default.
- W4312143485 cites W2074353056 @default.
- W4312143485 cites W2089263351 @default.
- W4312143485 cites W2118428239 @default.
- W4312143485 cites W2122825815 @default.
- W4312143485 cites W2141037581 @default.
- W4312143485 cites W2150949997 @default.
- W4312143485 cites W2170867270 @default.
- W4312143485 cites W2171344824 @default.
- W4312143485 cites W2476568892 @default.
- W4312143485 cites W2529951711 @default.
- W4312143485 cites W2603428373 @default.
- W4312143485 cites W2612518188 @default.
- W4312143485 cites W2783816299 @default.
- W4312143485 cites W2787553551 @default.
- W4312143485 cites W2885808532 @default.
- W4312143485 cites W2885858946 @default.
- W4312143485 cites W2889646458 @default.
- W4312143485 cites W2897248687 @default.
- W4312143485 cites W2911497803 @default.
- W4312143485 cites W2915654698 @default.
- W4312143485 cites W2986868963 @default.
- W4312143485 cites W3012821548 @default.
- W4312143485 cites W3044244264 @default.
- W4312143485 cites W3083433414 @default.
- W4312143485 cites W3120223020 @default.
- W4312143485 cites W3138529056 @default.
- W4312143485 cites W3147006194 @default.
- W4312143485 cites W3157805013 @default.
- W4312143485 cites W3159639089 @default.
- W4312143485 cites W3175237082 @default.
- W4312143485 cites W3177308961 @default.
- W4312143485 cites W3186842177 @default.
- W4312143485 cites W3192447201 @default.
- W4312143485 cites W4200290498 @default.
- W4312143485 cites W4210990885 @default.
- W4312143485 cites W4212786713 @default.
- W4312143485 cites W4220672913 @default.
- W4312143485 doi "https://doi.org/10.1016/j.drup.2022.100913" @default.
- W4312143485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36603431" @default.
- W4312143485 hasPublicationYear "2023" @default.
- W4312143485 type Work @default.
- W4312143485 citedByCount "2" @default.
- W4312143485 countsByYear W43121434852023 @default.
- W4312143485 crossrefType "journal-article" @default.
- W4312143485 hasAuthorship W4312143485A5002487860 @default.
- W4312143485 hasAuthorship W4312143485A5005153006 @default.
- W4312143485 hasAuthorship W4312143485A5015850101 @default.
- W4312143485 hasAuthorship W4312143485A5029636776 @default.
- W4312143485 hasAuthorship W4312143485A5049061801 @default.
- W4312143485 hasAuthorship W4312143485A5051324146 @default.
- W4312143485 hasAuthorship W4312143485A5057222500 @default.
- W4312143485 hasAuthorship W4312143485A5058970294 @default.
- W4312143485 hasAuthorship W4312143485A5061154616 @default.
- W4312143485 hasAuthorship W4312143485A5071336437 @default.
- W4312143485 hasAuthorship W4312143485A5076005692 @default.
- W4312143485 hasAuthorship W4312143485A5077972623 @default.
- W4312143485 hasConcept C101762097 @default.
- W4312143485 hasConcept C104317684 @default.
- W4312143485 hasConcept C127561419 @default.
- W4312143485 hasConcept C134320426 @default.
- W4312143485 hasConcept C150194340 @default.
- W4312143485 hasConcept C173396325 @default.
- W4312143485 hasConcept C185592680 @default.
- W4312143485 hasConcept C190283241 @default.
- W4312143485 hasConcept C2776694085 @default.
- W4312143485 hasConcept C2778239845 @default.
- W4312143485 hasConcept C29537977 @default.
- W4312143485 hasConcept C502942594 @default.
- W4312143485 hasConcept C54355233 @default.
- W4312143485 hasConcept C55493867 @default.